StarLIMS to Acquire Lonza’s MODA Platform

Turn/River Capital Acquires StarLIMS from Francisco Partners

January 13, 2026

Software

Turn/River Capital has acquired StarLIMS, a Hollywood, Florida–based laboratory informatics software provider, from Francisco Partners in a transaction valued at roughly $200 million. Turn/River plans to scale StarLIMS’ product and go-to-market capabilities — including AI integration — while CEO Trey Cook remains in place as Francisco Partners fully exits the investment.

STARLIMS Acquires Labstep

August 22, 2023

Cloud & SaaS

STARLIMS has acquired Labstep, integrating Labstep’s cloud-based Electronic Laboratory Notebook (ELN) into STARLIMS’ enterprise informatics suite to support customers from R&D through product commercialization. The acquisition expands STARLIMS’ R&D capabilities and adds a modern, user-friendly ELN used by universities and companies worldwide.

Matrix One Acquires Simploud to Add QMS and LIMS Capabilities

January 6, 2026

Software

Matrix One, a life sciences software provider backed by Lauxera Capital Partners, has acquired Simploud, a cloud-based maker of Quality Management System (QMS) and Laboratory Information Management System (LIMS) software. Simploud's products will be integrated into Matrix One's portfolio as Matrix QMS and Matrix LIMS to broaden the company's compliance and laboratory software offering for regulated life sciences and MedTech customers.

AstraZeneca Acquires Modella AI

January 15, 2026

AI & Machine Learning

AstraZeneca has acquired Modella AI, a Boston-based biomedical AI company, to integrate its multimodal foundation models and agentic AI platform into AstraZeneca's global oncology R&D organization. The deal expands an existing multi-year collaboration to accelerate clinical development, improve biomarker discovery, and drive data-driven decision-making across AstraZeneca's oncology pipeline; financial terms were not disclosed.

Zymergen Acquires Lodo Therapeutics

May 28, 2021

Biotechnology

Zymergen Inc. acquired Lodo Therapeutics Corporation from Accelerator Life Science Partners (ALSP), integrating Lodo’s metagenomic natural‑product discovery platform into Zymergen’s technology stack. ALSP had been an investor and operator of Lodo following a $17 million Series A and a collaboration with Genentech; the financial terms of the deal were not disclosed by ALSP in its announcement.

Arcesium Acquires Limina to Build a Unified Front-to-Back Investment Platform

February 2, 2026

Software

Arcesium has acquired Stockholm-based P/OMS provider Limina to integrate front-office portfolio and order management capabilities with Arcesium's middle- and back-office technology, creating a unified front-to-back investment platform. The entire Limina team will join Arcesium, strengthening Arcesium's product capabilities and European presence while positioning the firm for further global expansion.